Every Mental Health story tagged Conditions.
The new director of the Centers for Disease Control and Prevention, Erica Schwartz, has emphasized the importance of transparency and accountability in her first address to agency staff.
The FDA has approved Regeneron's Pasatru for fibrodysplasia ossificans progressiva (FOP), a rare condition causing abnormal bone growth. The drug aims to slow disease progression, potentially preserving mobility and extending lifespan for patients who often rely on wheelchairs by age 25.
A recent patient death has led experts to scrutinize Huidagene's disclosures, raising concerns about the company's transparency and safety protocols.
A Swedish cohort study found that patients with inflammatory bowel disease (IBD) are at increased risk for several psychiatric disorders both before and after diagnosis.